1. Jul 2026
Description
(AWP Alliance News) - Idorsia named Roland Wandeler as chief executive officer, effective Oct. 1, 2026, replacing interim CEO Jean-Paul Clozel. Wandeler is president of Biopharma at Grifols, previously held senior roles at Amgen, led a major US business unit, and served as chief operating officer at MorphoSys.
Clozel will remain chairman and stay on as CEO until the handover date. Benjamin Limal, president for Europe and international markets, will join the executive committee.
Dominique Le Terrier, general manager for France and Benelux, becomes head of global commercial strategy and new product planning, while Begoña Carreño-Gómez joins as chief business development officer from Nov. 1, 2026.
https://www.globenewswire.com/NewsRoom/ReleaseNg/402437111
Disclaimer: This news brief was created using generative artificial intelligence. Idorsia Ltd. published the original content used to generate this news brief via GlobeNewswire on July 01, 2026, and is solely responsible for the information contained therein.
